Nominations open for FDA Impact Award 2021

There is lots of fantastic work going on and our Impact Award is our way of recognising that work and saying thank you.
You can nominate a member, representative or branch who you think has made a difference in one (or more) of the following areas:
- Campaign: where a campaign has been run in a local area resulting in engaging members and/or a win on an issue.
- Engagement: members have been engaged to become more involved in the FDA, with high participation in branch structures/surveys or regular successful events.
- Branch development: introducing new forms of communication, recruiting members to the committee, increasing branch activity.
- Recruitment: where a large number of new members have been recruited, declining membership has been reversed, or where members have been recruited from unengaged areas or despite challenging circumstances.
- Casework: where a significant win has been achieved, a win on a difficult case or a win on a case that has resulted in wider change in the department.
- Negotiation: where a win has been achieved for members through negotiations with the employer.
To nominate an outstanding member, workplace rep or branch please complete this form and return by email to amy@fda.org.uk by midday Monday 12th April.
Related News
-
FDA rejects claims civil service to blame for delays to Northern Ireland infrastructure projects
The FDA’s National Officer for Northern Ireland Robert Murtagh has spoken out against claims that the Northern Ireland Civil Service, were to blame for the failure of infrastructure projects to be completed on time.
-
Penman joins panel discussion on ethical leadership in government at IfG ‘Nolan Principles at 30’ conference
FDA General Secretary Dave Penman took part in a panel discussion covering the question ‘How can politicians demonstrate ethical leadership?’.
-
Carers Week 2025 – launching our Carers’ Survey
To mark Carers Week 2025 (9-15 June), the FDA is launching a survey of carers in the civil service to find out what progress has been made since our 2021 report, and what still needs to be done.